Case Study

Meeting GMP Requirements For Closed Handling Of Vial Stopper Components In Filling Operations

Source: Chargepoint Technology

By Christian Dunne , Aseptic Global Product Manager , Chargepoint Technology

AS-valve-key-brand-

In 2011 the State Food and Drug Administration of China (SFDA) published a revised version of the GMP regulation. Hence, all new and upgraded manufacturing facilities will need to comply with these requirements with strict deadlines for existing manufacturers of sterile products.

The client needed to upgrade their facility to meet GMP requirements for closed handling of vial stopper components from an autoclave to a filling line. The room background classification was a Grade B which means the critical area handling must be maintained under sealed conditions once sterilised.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online